Yale School of Management - Fuad El-Hibri '82

"What’s unique about Yale SOM is the combined private and public management approach with a strong focus on entrepreneurship and leadership. These, along with a student-teacher ratio that is conducive to optimal learning, provide a solid foundation and broad understanding of business concepts that give students the confidence and wherewithal to succeed. I am proud to be a graduate of Yale SOM."

Fuad El-Hibri is the founder and executive chairman of the board of Emergent BioSolutions Inc. He served as chief executive officer of Emergent from its inception in 1998 until March 31, 2012. Emergent is a publicly held U.S. biopharmaceutical company with global operations across multiple sites, focused on the development, manufacture, and commercialization of vaccines and therapeutics. Emergent is a reliable and long-standing partner to the U.S. government through its development, manufacture, and delivery of BioThrax® (Anthrax Vaccine Adsorbed), the only FDA-licensed anthrax vaccine. Since 2003, through a series of company and asset acquisitions, Emergent has broadened its pipeline to include investigational products that target infectious diseases, oncology, and autoimmune disorders.

For over two decades, Mr. El-Hibri has served as chairman of East West Resources Corporation, a venture capital and financial consulting firm. He founded, commercialized, and then sold mobile telecommunications companies in Russia, Venezuela, and El Salvador, namely, Mobile Telesystems, Digitel, and Digicel. Mr. El-Hibri began his career with Citigroup in commercial banking and subsequently in mergers and acquisitions. He then joined Booz Allen Hamilton as a management and strategic consultant in South East Asia.

Mr. El-Hibri is the chairman of the El-Hibri Charitable Foundation and is a member of the board of directors of the U.S. Chamber of Commerce. He is a member of the board of trustees of the International Biomedical Research Alliance and of the National Health Museum. He also serves on the advisory boards of the Yale Healthcare Conference and the Heifetz International Music Institute.

Mr. El-Hibri has received several awards including Executive of the Year from the Tech Council of Maryland in 2012, Biotech CEO of the Year from the World Vaccine Congress in 2011, the International Leadership Award from the World Trade Center Institute in 2010, the Ernst & Young Entrepreneur of the Year for Greater Washington in 2009, and the Rene Moawad Foundation Distinguished Community Service and Achievement Award in 2007. Mr. El-Hibri received a master's degree in public and private management from Yale University and a BA with honors in economics from Stanford University.